Keron Morris’ practice includes assisting clients in government review of mergers, complex civil antitrust litigation, and filing obligations under the Hart-Scott-Rodino Act. Keron also counsels clients on a range of antitrust and consumer protection issues. Keron has represented clients in a variety of industries, including aerospace, book publishing, health care, health insurance, hospitality, industrials, medical devices, oil and gas, supermarket, and telecommunications.
Keron maintains an active pro bono practice, primarily representing criminal defendants in felony cases in D.C. Superior Court. Keron personally represents clients from arrest to disposition, including trial and negotiations with the government. In one of these cases, he obtained a jury verdict acquitting his client on all felony charges in a drug distribution trial.
Keron graduated from Harvard Law School. During law school, Keron served as a student attorney in the Harvard Law School Criminal Justice Institute, where he also represented indigent criminal defendants. Keron completed his undergraduate degree at Wake Forest University where he graduated magna cum laude.
- AT&T in its successful $85.4 billion stock-and-cash acquisition of Time Warner Inc. After a second request and the first vertical merger trial/appeal in decades, the transaction was approved with no finding of liability.
- Boston Scientific in its $1.07 billion acquisition of Lumenis LTD from Baring Private Equity Asia.
- BP in its approximately $10.5 billion acquisition of BHP Billiton’s U.S. onshore shale assets.
- BP in its acquisition of the remaining interests in Thorntons LLC, a leading gasoline and convenience store chain located in the Midwest and Florida, from its joint venture partner, Arclight Capital Partners.
- HarperCollins Publishers, a subsidiary of News Corporation, in its $349 million acquisition of Books & Media segment of Houghton Mifflin Harcourt.
- Kroger in its sale of You Technology LLC, its digital coupon and rebate publishing unit, to Inmar.
- National Titanium Dioxide Company Limited (d/b/a Cristal) in its approximately $2.4 billion sale of its titanium dioxide business to Tronox Limited.
- NxStage Medical Inc. in its $2 billion sale to Fresenius Medical Care Holdings Inc.
- HarperCollins Publishers, in defense of antitrust class action litigation involving the pricing of electronic and print books. (U.S. District Court, SDNY).
- Mallinckrodt Pharmaceuticals in defense of federal and state class action and non-class action litigation involving antitrust and marketing-related claims regarding one of its leading products.
- J.D., Harvard Law School, 2015
- B.A., Wake Forest University, 2009, magna cum laude, with honors
- District of Columbia
- South Carolina
- U.S. District Court, District of Columbia